Key terms

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BMY news

Apr 12 6:00am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and Roche Holding AG (OtherRHHVF) by TipRanks Apr 12 5:25am ET Bristol-Myers Squibb: A Buy Rating on Undervaluation and Promising Product Portfolio by TipRanks Apr 08 11:33am ET Bristol Myers: Krazati plus cetuximab showed ORR of 34%, PFS of 6.9 months by TipRanks Apr 08 5:47am ET Bristol-Myers Squibb’s Hold Rating: Balancing KarXT’s Efficacy and Safety with Financial Uncertainties by TipRanks Apr 07 6:44am ET Bristol Myers presents new data from Phase 3 EMERGENT program evaluating KarXT by TipRanks Apr 07 6:34am ET Bristol Myers presents new interim long-term efficacy data from EMERGENT-4 trial by TipRanks Apr 05 9:08am ET Bristol Myers, 2seventy Bio’s Abecma approved by U.S. FDA by TipRanks Apr 03 4:03pm ET Standard BioTools announces multi-year agreement with Bristol Myers by TipRanks Apr 03 5:56am ET Bristol Myers: European Commission expands approval of Reblozyl by TipRanks Apr 03 5:16am ET Wells Fargo Sticks to Its Hold Rating for Bristol-Myers Squibb (BMY) by TipRanks Apr 01 7:39am ET Zai Lab, Bristol Myers: Krazati confirmatory trial meets PFS primary endpoints by TipRanks Mar 31 5:25am ET Ex-Dividend Date Nearing for These 10 Stocks – Week of April 1, 2024 by TipRanks Mar 29 8:30am ET Bristol Myers ends collaboration agreement with Molecular Templates by TipRanks Mar 28 5:20pm ET Bristol Myers Squibb (NYSE:BMY) Slips after Disappointing Drug Trial by TipRanks Mar 28 4:15pm ET Bristol Myers says KRYSTAL-12 trial met primary endpoint in PFS by TipRanks Mar 28 4:02pm ET Bristol Myers: Phase 3 YELLOWSTONE trial did not meet primary endpoint by TipRanks Mar 25 11:46am ET Bristol Myers Squibb call volume above normal and directionally bullish by TipRanks Mar 20 4:52pm ET Bristol Myers’ Abecma approved in the EU for multiple myeloma by TipRanks Mar 20 7:05am ET Bristol Myers says Phase 3 CheckMate -9DW trial met primary endpoint by TipRanks Mar 20 7:01am ET Bristol Myers announces the Phase 3 CheckMate -9DW trial by TipRanks Mar 19 1:32pm ET This radiopharma name seen as ‘poised for takeout’ following Fusion deal by TipRanks Mar 19 12:55pm ET Actinium Pharmaceuticals price target raised to $30 from $20 at Maxim by TipRanks Mar 19 1:37am ET Hold Rating on Bristol-Myers Squibb Amidst NSCLC Trial Uncertainties and Pending KarXT Results by TipRanks Mar 18 5:52pm ET Gerald Storch Exits, Bristol-Myers Squibb Board Shrinks by TipRanks Mar 18 9:19am ET Arcellx price target raised to $81 from $72 at Needham by TipRanks Mar 18 9:07am ET Bristol Myers completes acquisition of Karuna Therapeutics by TipRanks Mar 18 8:15am ET Perspective Therapeutics announces collaboration agreement with Bristol Myers by TipRanks Mar 18 5:15am ET Hold Rating on Bristol-Myers Squibb Amid Mixed Clinical Outcomes and Market Competition by TipRanks Mar 15 6:30pm ET Bristol Myers, 2seventy Bio: FDA’s ODAC votes in favor of Abecma by TipRanks Mar 15 12:03pm ET JPMorgan biotech/pharma analysts hold an analyst/industry conference call by TipRanks Mar 15 5:11am ET Bristol Myers announces FDA grants accelerated approval of Breyanzi by TipRanks
Yesterday 9:30am ET Better Buy: Bristol Myers Squibb or the Vanguard S&P 500 ETF? by Motley Fool Yesterday 9:00am ET Better Growth Play: Merck or The Vanguard Growth Index Fund? by Motley Fool Apr 09 4:21am ET 3 Dividend Growth Stocks With Yields Above 3% That You Can Buy and Hold for the Next Decade by Motley Fool Apr 08 3:34am ET Down 75%. Is Agenus Stock a Buy on the Dip? by Motley Fool Apr 03 4:19am ET 2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now? by Motley Fool Mar 28 8:15am ET Is Bristol Myers Squibb Stock a Buy? by Motley Fool
Apr 14 10:16am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile Apr 11 9:10am ET Building a Better Future: Bristol Myers Squibb 2023 ESG Report by Accesswire Apr 08 7:00am ET Bristol Myers Squibb Releases 2023 ESG Report Demonstrating Progress and Setting New Long-Term Goals by Accesswire Apr 06 3:02pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile Apr 02 2:30pm ET Bristol Myers Squibb Releases 2023 Environmental, Social and Governance Report Demonstrating Progress and Setting New Long-Term Goals by Accesswire Mar 29 11:26am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile Mar 29 9:45am ET Bristol Myers Squibb Expands Health Equity Grant Initiatives to Improve Health Outcomes by Accesswire Mar 21 1:28pm ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile Mar 14 8:15am ET SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY by Newsfile

BMY Financials

1-year income & revenue

Key terms

BMY Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BMY Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments
People walk past the New York Stock Exchange (NYSE) on April 10, 2024 in New York City.
Spencer Platt/Getty Images
Dow closes nearly 500 points lower on fears of potential Iranian attack on Israel
JPMorgan beat earnings expectations this Friday, unofficially kicking off the first quarter earnings season.
Win McNamee/Getty Images
Jamie Dimon says chance of a bad economy is ‘higher than other people think’